Driving Scalable Healthcare Growth Through Omnichannel Demand Generation, P&L Leadership, and Strategic Expansion
Indira IVF Group has appointed Devendrasingh Rajput as Chief Growth Officer, marking a significant progression in a career spanning healthcare, diagnostics, pharmaceuticals, business development, operations, sales, marketing, and strategic growth.
Based in Mumbai, Maharashtra, Rajput brings extensive leadership experience across India’s healthcare and diagnostics ecosystem, with a career defined by business transformation, geographic expansion, P&L management, strategic partnerships, and commercial execution.
In his new role, Rajput is focused on building scalable growth engines by integrating B2B and B2C strategies, omnichannel demand generation, marketing, sales, operations, and project execution. His mandate reflects an increasingly integrated approach to healthcare growth–one that connects customer acquisition, clinical services, operational excellence, and sustainable profitability.
Leading Growth Strategy at Indira IVF Group
As Chief Growth Officer at Indira IVF Group, Rajput is responsible for advancing the organization’s growth agenda through a combination of corporate strategy, P&L leadership, demand generation, and cross-functional execution.
His leadership philosophy centers on bridging the gap between high-level strategy and operational delivery. By aligning marketing, sales, operations, and project deployment, he aims to create market-responsive business engines capable of delivering predictable and sustainable growth.
His role encompasses omnichannel demand generation, with a focus on developing data-driven funnels that acquire, convert, and retain both B2B clients and B2C consumers.
Rajput’s expanded mandate builds upon his previous experience as Chief Business Officer at Indira IVF, where he worked across IVF, pathology, pharmacy, sales, marketing, and new projects.
Driving Business Expansion as Chief Business Officer
Before becoming Chief Growth Officer, Rajput served as Chief Business Officer at Indira IVF Group from August 2024 to August 2026.
During this period, he was responsible for driving growth across IVF, pathology, and pharmacy verticals, while managing P&L responsibilities covering pharmacy supply chain, diagnostics operations, and new projects.
His mandate also included developing business strategies for healthcare professional engagement, B2B channel development, pathology and pharmacy operations, as well as improving service delivery and customer satisfaction.
A key component of his leadership was strategic geographic expansion, including initiatives focused on building new hospitals and IVF centers.
This experience provided Rajput with a broad understanding of the interconnected nature of healthcare businesses, where commercial growth must be supported by operational infrastructure, clinical capabilities, customer experience, and efficient execution.
Transforming Diagnostics at Apollo Health and Lifestyle
Rajput’s leadership journey gained significant momentum during his four-year tenure at Apollo Health and Lifestyle Limited, where he served as Chief Operating Officer – Diagnostics from July 2020 to August 2024.
His tenure was marked by substantial growth and operational transformation.
According to his profile, he delivered 3X revenue growth and 4X network growth over four years, while maintaining double-digit EBITDA.
He also expanded the company’s diagnostic footprint across India through strategic partnerships and digital outreach initiatives, launching more than 75 processing laboratories and a network of more than 2,000 collection centers.
Rajput additionally worked on enhancing digital service offerings through platforms including Apollo 24|7, Companion Diagnostics, and central laboratory services, contributing to stronger customer engagement and retention.
His experience at Apollo demonstrates his ability to combine large-scale network expansion with technology-enabled service delivery and operational discipline.
Building International Diagnostics Markets at Quest Diagnostics
Prior to Apollo, Rajput served as Managing Director – South Asia at Quest Diagnostics from December 2013 to May 2019.
Based in India, he was responsible for strategic geographical expansion of the company’s reference testing portfolio across the Asia-Pacific region.
One of his significant areas of focus was developing partnerships with laboratories across markets including Hong Kong, Japan, South Korea, Australia, Indonesia, the Philippines, and Sri Lanka.
He also helped launch the Global Diagnostics Network (GDN) in APAC and onboard strategic partners across South Korea, Australia, Singapore, and India.
According to his profile, the reference testing and employer solutions business achieved 3X revenue growth between 2015 and 2018.
His responsibilities extended across international business operations, Companion Diagnostics, clinical-trial projects, employer solutions, and the development of networks involving laboratories, physicians, and healthcare providers.
This period established Rajput as a leader capable of taking healthcare businesses across borders while building sustainable partner ecosystems.
Expanding International Operations at Neuberg Diagnostics
In 2019, Rajput joined Neuberg Diagnostics as Vice President – International Operations.
His responsibilities included international business operations and market development across East Africa and Southeast Asia.
The role further strengthened his expertise in international healthcare expansion, project management, diagnostics, and market development.
It also complemented his previous experience at Quest Diagnostics, where he had developed extensive exposure to healthcare partnerships and international markets.
Establishing Healthcare Businesses in Sri Lanka
Earlier in his career, Rajput spent more than three years with Metropolis Healthcare Limited, serving as Country Head – Sri Lanka.
As Profit Center Head for Nawaloka Metropolis Laboratories, he managed a broad portfolio spanning sales and marketing, business development, logistics, accounts, human resources, project management, procurement, inventory, training, and administration.
His tenure was characterized by significant geographical and operational expansion.
According to his profile, he achieved 3X revenue and network growth between 2010 and 2013, while maintaining a positive bottom line.
He established 10 new laboratories across different geographical locations in Sri Lanka, including the northern and eastern regions, and helped establish a reference laboratory with advanced diagnostic capabilities including molecular biology and histopathology.
He also conceptualized and implemented marketing and public-awareness campaigns while introducing business transformation initiatives focused on laboratory operations and patient experience.
The experience demonstrated Rajput’s ability to manage an entire healthcare business ecosystem–from commercial development and infrastructure expansion to people management and customer experience.
Building Regional Business Development Capabilities
Rajput’s international and commercial healthcare experience began developing much earlier.
At Metropolis Health Services, he served as Zonal Manager – Business Development, working across national and international business development, sales and marketing, key-account management, SAARC markets, East Africa, Sri Lanka projects, and public-private partnerships.
Before that, at AGILUS Diagnostics, formerly SRL Limited, he served as Sales Manager – SAARC Region, where he focused on regional sales and marketing, collection-center and distribution-network development, logistics management, and product management across molecular, oncology, and genetics diagnostic services.
These positions established a foundation in healthcare commercial operations and international market development.
Expanding Diagnostics and Biotechnology at Reliance Life Sciences
From 2004 to 2007, Rajput served as Regional Head at Reliance Life Sciences, where he was involved in launching diagnostics, biotechnology, and stem-cell banking divisions across Maharashtra, Madhya Pradesh, and Chhattisgarh.
He developed channel and pharmaceutical distribution networks for products and diagnostic services and conducted continuing medical education programs and round-table meetings with specialist doctors.
He also led training initiatives for business associates and sales teams.
This role broadened his exposure beyond traditional pharmaceutical sales into emerging healthcare and biotechnology businesses.
Building a Strong Pharmaceutical Foundation at Novartis
Rajput began his healthcare career in 1996 and spent nearly seven years with Novartis India, where he worked as a Product Specialist across multiple business divisions.
His responsibilities included key-account management, distribution management, hospital sales, and engagement with healthcare professionals across specialties such as orthopaedics, neurology, cardiology, nephrology, and general medicine.
His performance included being ranked No. 1 in the Diovan division in 2003 and receiving recognition as Best Zonal Representative in 1998 and 2001, according to his profile.
This early experience gave Rajput a strong grounding in pharmaceutical sales, healthcare-provider engagement, market development, and commercial execution.
From Pharmaceutical Sales to Enterprise Growth Leadership
Rajput’s career represents a remarkable evolution across the healthcare value chain.
Beginning as a medical representative, he progressed through pharmaceutical sales and key-account management into regional business development, diagnostics, international operations, P&L leadership, and enterprise-level growth strategy.
His journey has consistently combined three critical capabilities:
- Commercial growth and demand generation
- Operational and P&L management
- Strategic healthcare expansion
This combination has enabled him to operate across both B2B enterprise partnerships and B2C healthcare markets, giving him a comprehensive perspective on how healthcare organizations can scale.
Building the Next Phase of Healthcare Growth
Healthcare businesses are increasingly required to balance growth with operational efficiency, patient experience, digital engagement, and financial sustainability.
Rajput’s experience aligns closely with these priorities.
His background in diagnostics network expansion, healthcare partnerships, digital platforms, geographic market development, demand generation, and P&L management positions him to approach growth as an integrated business discipline rather than as an isolated sales or marketing function.
At Indira IVF Group, this perspective can support the continued evolution of growth strategies across IVF, diagnostics, pharmacy, and related healthcare services.
His emphasis on omnichannel demand generation also reflects the changing way patients and healthcare consumers discover, evaluate, and access healthcare services.
A Leadership Philosophy Centered on Scalable Growth
Rajput’s career demonstrates that sustainable growth requires more than increasing revenue.
It requires building the right infrastructure, developing capable teams, creating strong partnerships, understanding customer needs, and establishing processes that can scale across markets.
From expanding diagnostic networks in India to developing international laboratory partnerships and managing healthcare businesses across multiple functions, his career has repeatedly involved translating strategic objectives into measurable operational outcomes.
As Chief Growth Officer, he now brings this experience into a broader mandate—connecting strategy, demand generation, marketing, sales, operations, partnerships, and financial performance.
Shaping the Future of Healthcare Growth at Indira IVF Group
Rajput’s appointment as Chief Growth Officer at Indira IVF Group represents the latest step in a career spanning more than three decades across pharmaceuticals, diagnostics, biotechnology, healthcare operations, and business leadership.
His experience across organizations including Novartis India, Reliance Life Sciences, Metropolis Healthcare, Quest Diagnostics, Neuberg Diagnostics, Apollo Health and Lifestyle, and Indira IVF Group has provided him with a broad understanding of healthcare markets and the mechanisms required to scale them.
As he takes on his expanded leadership mandate, his focus on P&L management, omnichannel demand generation, strategic expansion, operational execution, and cross-functional integration positions him to contribute to the next phase of Indira IVF Group’s growth journey.
His professional story is ultimately one of progression–from frontline healthcare sales to enterprise leadership–with each stage adding another layer of expertise in building businesses, developing markets, and creating sustainable growth.
CXO Gateway Perspective
CXO Gateway continues to spotlight leaders who are shaping the future of business through strategic thinking, operational excellence, and transformative leadership. Devendrasingh Rajput’s appointment as Chief Growth Officer at Indira IVF Group highlights the increasing importance of integrated growth leadership within India’s rapidly evolving healthcare sector.
His journey across pharmaceuticals, diagnostics, international healthcare markets, and large-scale operations demonstrates how commercial insight, strategic partnerships, technology, and disciplined execution can come together to create sustainable healthcare growth.